These consistent shifts underscore both the elevated prevalence of TP53 and GATA3 alterations and the relative paucity of PIK3CA mutations in African breast cancers when benchmarked against a predominantly European-ancestry reference Fig. 6. This evidence concerns the gene PIK3CA and breast carcinoma.